1282 related articles for article (PubMed ID: 25131830)
1. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.
Falkenberg KJ; Johnstone RW
Nat Rev Drug Discov; 2014 Sep; 13(9):673-91. PubMed ID: 25131830
[TBL] [Abstract][Full Text] [Related]
2. Histone Deacetylase Inhibitors in Cancer Therapy.
Sun Y; Sun Y; Yue S; Wang Y; Lu F
Curr Top Med Chem; 2018; 18(28):2420-2428. PubMed ID: 30526462
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in histone deacetylase targeted cancer therapy.
Hoshino I; Matsubara H
Surg Today; 2010 Sep; 40(9):809-15. PubMed ID: 20740342
[TBL] [Abstract][Full Text] [Related]
4. HDAC modulation and cell death in the clinic.
Dell'Aversana C; Lepore I; Altucci L
Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671
[TBL] [Abstract][Full Text] [Related]
5. Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer.
Bai Y; Ahmad D; Wang T; Cui G; Li W
Curr Top Med Chem; 2019; 19(12):995-1004. PubMed ID: 30686256
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of histone deacetylases in cancer.
Montezuma D; Henrique RM; Jerónimo C
Crit Rev Oncog; 2015; 20(1-2):19-34. PubMed ID: 25746102
[TBL] [Abstract][Full Text] [Related]
7. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
8. HDAC11: a rising star in epigenetics.
Liu SS; Wu F; Jin YM; Chang WQ; Xu TM
Biomed Pharmacother; 2020 Nov; 131():110607. PubMed ID: 32841898
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
Ramaiah MJ; Tangutur AD; Manyam RR
Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
[TBL] [Abstract][Full Text] [Related]
10. New and emerging HDAC inhibitors for cancer treatment.
West AC; Johnstone RW
J Clin Invest; 2014 Jan; 124(1):30-9. PubMed ID: 24382387
[TBL] [Abstract][Full Text] [Related]
11. Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions.
Vaidya GN; Rana P; Venkatesh A; Chatterjee DR; Contractor D; Satpute DP; Nagpure M; Jain A; Kumar D
Eur J Med Chem; 2021 Jan; 209():112844. PubMed ID: 33143937
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells.
Zhang S; Zhan L; Li X; Yang Z; Luo Y; Zhao H
Int J Biol Sci; 2021; 17(13):3381-3400. PubMed ID: 34512154
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 10, a potential epigenetic target for therapy.
Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Niu Z; He W
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33997894
[TBL] [Abstract][Full Text] [Related]
14. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach.
Ranganna K; Selvam C; Shivachar A; Yousefipour Z
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147762
[TBL] [Abstract][Full Text] [Related]
15. Histone Deacetylase Modifications by Probiotics in Colorectal Cancer.
Salek Farrokhi A; Mohammadlou M; Abdollahi M; Eslami M; Yousefi B
J Gastrointest Cancer; 2020 Sep; 51(3):754-764. PubMed ID: 31808058
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
17. [Histone deacetylase inhibitors: highlight on epigenetic regulation].
Pécuchet N; Cluzeau T; Thibault C; Mounier N; Vignot S
Bull Cancer; 2010 Aug; 97(8):917-35. PubMed ID: 20483706
[TBL] [Abstract][Full Text] [Related]
18. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
Li Z; Zhu WG
Int J Biol Sci; 2014; 10(7):757-70. PubMed ID: 25013383
[TBL] [Abstract][Full Text] [Related]
19. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
[TBL] [Abstract][Full Text] [Related]
20. Classical HDACs in the regulation of neuroinflammation.
Dai Y; Wei T; Shen Z; Bei Y; Lin H; Dai H
Neurochem Int; 2021 Nov; 150():105182. PubMed ID: 34509559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
